Ayesha Zahid is a PhD researcher in microbiology, immunology, and biotechnology at the Institute for Glycomics, Griffith University, where she also serves as a Lecturer in Biomedical Sciences. She holds a Bachelor of Science and a Master’s by Research in Biotechnology, both awarded with gold medals for academic excellence. Her doctoral research, supported by the Earbus Foundation of Western Australia, focuses on the development of a multicomponent vaccine for otitis media, a leading cause of hearing loss in children. This work involves the use of novel protein antigens from Nontypeable Haemophilus influenzae and Moraxella catarrhalis, combined with genetically modified outer-membrane vesicles (OMVs), to enhance vaccine safety and immunogenicity. Her broader research interests include host–pathogen interactions, mucosal immunity, inflammasome biology, and innovative biotechnological approaches for infectious disease prevention. She has authored several peer-reviewed publications in high-impact journals and has presented her work at national and international scientific forums. Passionate about translational research, she is dedicated to bridging the gap between fundamental science and clinical application. Ayesha is an active member of the Australian Society for Microbiology, the Australian and New Zealand Society for Immunology, the International Society for Extracellular Vesicles, and the International Society for Vaccines.
Ayesha Zahid is a PhD researcher in microbiology, immunology, and biotechnology at the Institute for Glycomics, Griffith University, where she also serves as a Lecturer in Biomedical Sciences. She holds a Bachelor of Science and a Master’s by Research in Biotechnology, both awarded with gold medals for academic excellence. Her doctoral research, supported by the Earbus Foundation of Western Australia, focuses on the development of a multicomponent vaccine for otitis media, a leading cause of hearing loss in children. This work involves the use of novel protein antigens from Nontypeable Haemophilus influenzae and Moraxella catarrhalis, combined with genetically modified outer-membrane vesicles (OMVs), to enhance vaccine safety and immunogenicity. Her broader research interests include host–pathogen interactions, mucosal immunity, inflammasome biology, and innovative biotechnological approaches for infectious disease prevention. She has authored several peer-reviewed publications in high-impact journals and has presented her work at national and international scientific forums. Passionate about translational research, she is dedicated to bridging the gap between fundamental science and clinical application. Ayesha is an active member of the Australian Society for Microbiology, the Australian and New Zealand Society for Immunology, the International Society for Extracellular Vesicles, and the International Society for Vaccines.